WHO ICTRP trial
Identifying new tumour markers in oesophageal (gullet) and gastroesophageal…
ISRCTN11063656 · International Standard Randomised Controlled Trial Number (ISRCTN) · Not Recruiting
Key facts
| Trial ID | ISRCTN11063656 |
|---|---|
| Public title | Identifying new tumour markers in oesophageal (gullet) and gastroesophageal (stomach/gullet) cancers |
| Scientific title | Proteomic Profiling of Oesophageal Adenocarcinoma Neoantigens |
| Primary sponsor | University of Dundee |
| Registry | International Standard Randomised Controlled Trial Number (ISRCTN) |
| Recruitment status | Not Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | England;Northern Ireland;Scotland;United Kingdom;Wales |
| Conditions | Oesophageal cancer Cancer |
| Interventions | Medical history • To confirm eligibility • Location of primary tumour • Histological and molecular diagnosis details – Human epidermal growth factor receptor 2 (HER2), PD-L1 testing • Tumour stage according to AJCC/UICC version 8 for… |
| Registration date | Aug 19, 2022 |
| Target size | 75 |
| Secondary IDs | Nil known;Nil known;2-014-22, IRAS 309452 |
| Registry page | isrctn.com |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: